advertisement
 

  Back to Double Diabetes Summary Medical Treatment Of Double Diabetes

Medical Treatment Of Double Diabetes

Everyone with type 1 diabetes requires insulin therapy. If it's determined that a person with type 1 diabetes also has type 2 diabetes there might be a need for blood glucose-lowering pills, particularly those that improve insulin resistance. Since double diabetes is a new problem, doctors have not had enough experience - or performed enough research - to decide what treatment approaches are most effective.

Since the control of blood glucose is critical, some doctors believe that blood glucose lowering pills might improve glucose control. There are a number of research studies underway which will provide guidance within the next few years. In the meantime, maintaining glucose control, achieving weight loss, being physically active and eating a nutritious diet are essential to managing double diabetes and decreasing complications.

At the time of diagnosis, if the type of diabetes cannot be determined, the child or teenager should start insulin therapy while waiting for test results that, hopefully, will clarify the situation.

Treatment for high blood pressure, abnormal blood lipids and elements of PCOS should follow standard treatments for these disorders.

«« Back to Type 2 and Double Diabetes
« Prev: Managing Double Diabetes | Next: Healthy Lifestyle Helps Double Diabetes »


                 
  Home Return to Top

Last Updated: Saturday April 20, 2013 13:31:34
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.